Vertex Pharma (VRTX) Tops Q1 EPS by 4c; Reiterates Outlook
Tweet
Share
E-mail
Get Alerts VRTX Hot Sheet
Price: $547.55 +0.05%
Financial Fact:
Loss from operations: -18.73M
Today's EPS Names:
VIVE, ENSV, MDLM, More
Financial Fact:
Loss from operations: -18.73M
Today's EPS Names:
VIVE, ENSV, MDLM, More
Join SI Premium – FREE
Vertex Pharma (NASDAQ: VRTX) reported Q1 EPS of $3.52, $0.04 better than the analyst estimate of $3.48. Revenue for the quarter came in at $2.1 billion versus the consensus estimate of $2.07 billion.
GUIDANCE:
Vertex Pharma reiterates FY2022 revenue of $8.4-8.6 billion, versus the consensus of $8.58 billion.
For earnings history and earnings-related data on Vertex Pharma (VRTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The Gap, Inc. (GAP) Tops Q2 EPS by 3c
- Rubrik (RBRK) Tops Q2 EPS by 16c, Beats on Revenue; Offers FY27 EPS Guidance
- Build-A-Bear Workshop (BBW) Tops Q2 EPS by 3c, Misses on Revenue; Offers FY Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
